scholarly journals Corrigendum to: The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study

2019 ◽  
Vol 40 (14) ◽  
pp. 1157-1157
2018 ◽  
Vol 40 (14) ◽  
pp. 1149-1157 ◽  
Author(s):  
Ali Azarbarzin ◽  
Scott A Sands ◽  
Katie L Stone ◽  
Luigi Taranto-Montemurro ◽  
Ludovico Messineo ◽  
...  

SLEEP ◽  
2005 ◽  
Vol 28 (2) ◽  
pp. 207-214 ◽  
Author(s):  
Andrew P. Levy ◽  
Lin Zhang ◽  
Rachel Miller-Lotan ◽  
Susan Redline ◽  
George T. O'Connor ◽  
...  

Neurology ◽  
2007 ◽  
Vol 70 (1) ◽  
pp. 35-42 ◽  
Author(s):  
J. W. Winkelman ◽  
E. Shahar ◽  
I. Sharief ◽  
D. J. Gottlieb

2020 ◽  
Vol 12 (S2) ◽  
pp. S129-S138
Author(s):  
Matteo Bradicich ◽  
Noriane A. Sievi ◽  
Fabian A. Grewe ◽  
Alessio Gasperetti ◽  
Malcolm Kohler ◽  
...  

Author(s):  
Bin Yan ◽  
Jian Yang ◽  
Binbin Zhao ◽  
Yajuan Fan ◽  
Wei Wang ◽  
...  

Background There was little evidence about the role of objective sleep efficiency (SE) in the incidence of major cardiovascular disease (CVD) events. The purpose of this study was to investigate the correlation between objective SE and CVD based on polysomnography. Methods and Results A total of 3810 participants from the SHHS (Sleep Heart Health Study) were selected in the current study. CVD was assessed during an almost 11‐year follow‐up period. The primary composite cardiovascular outcome was major adverse cardiovascular events, defined as CVD mortality, congestive heart failure, myocardial infarction, and stroke. The secondary composite cardiovascular outcome was major adverse cardiovascular event plus revascularization. Objective measured SE, including SE and wake after sleep onset, was based on in‐home polysomnography records. Cox regression analysis was used to explore the association between SE and CVD. After multivariate Cox regression analysis, poor SE (<80%) was significantly associated with primary (hazard ratio [HR], 1.338; 95% CI, 1.025–1.745; P =0.032) and secondary composite cardiovascular outcomes (HR, 1.250; 95% CI, 1.027–1.521; P =0.026); it was also found to be a predictor of CVD mortality (HR, 1.887; 95% CI, 1.224–2.909; P =0.004). Moreover, wake after sleep onset of fourth quartile (>78.0 minutes) was closely correlated with primary (HR, 1.436; 95% CI, 1.066–1.934; P =0.017), secondary composite cardiovascular outcomes (HR, 1.374; 95% CI, 1.103–1.712; P =0.005), and CVD mortality (HR, 2.240; 95% CI, 1.377–3.642; P =0.001). Conclusions Poor SE and long wake after sleep onset, objectively measured by polysomnography, were associated with the increased risk of incident CVD.


SLEEP ◽  
2018 ◽  
Vol 41 (6) ◽  
Author(s):  
Suzanne M Bertisch ◽  
Benjamin D Pollock ◽  
Murray A Mittleman ◽  
Daniel J Buysse ◽  
Lydia A Bazzano ◽  
...  

2021 ◽  
pp. 2101958
Author(s):  
Bastien Lechat ◽  
Sarah Appleton ◽  
Yohannes Adama Melaku ◽  
Kristy Hansen ◽  
R. Doug McEvoy ◽  
...  

Study ObjectivesIncreased mortality has been reported in people with insomnia and in those with obstructive sleep apnoea (OSA). However, these conditions commonly co-occur and the combined effect of co-morbid insomnia and sleep apnoea (COMISA) on mortality risk is unknown. This study used Sleep Heart Health Study (SHHS) data to assess associations between COMISA and all-cause mortality risk.MethodsInsomnia was defined as difficulties falling asleep, maintaining sleep, and/or early morning awakenings from sleep ≥16 times a month and daytime impairment. OSA was defined as an apnoea-hypopnoea index ≥15 events/h sleep. COMISA was defined if both conditions were present. Multivariable adjusted Cox proportional hazard models were used to determine the association between COMISA and all-cause mortality (n=1210) over 15 years of follow-up.Results5236 participants were included. 2708 (52%) did not have insomnia/OSA (control), 170 (3%) had insomnia-alone, 2221 (42%) had OSA-alone, and 137 (3%) had COMISA. COMISA participants had a higher prevalence of hypertension (ORs [95%CI]; 2.00 [1.39, 2.90]) and cardiovascular disease compared to controls (1.70 [1.11, 2.61]). Insomnia-alone and OSA-alone were associated with higher risk of hypertension but not cardiovascular disease compared to controls. Compared to controls, COMISA was associated with a 47% (HR, 95% CI; 1.47 (1.06, 2.07)) increased risk of mortality. The association between COMISA and mortality was consistent across multiple definitions of OSA and insomnia.ConclusionsCo-morbid insomnia and sleep apnoea was associated with higher rates of hypertension and cardiovascular disease at baseline, and an increased risk of all-cause mortality compared to no insomnia/OSA.


Sign in / Sign up

Export Citation Format

Share Document